The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Express Scripts to Present at Upcoming Conferences

Wednesday, February 20, 2013

Express Scripts to Present at Upcoming Conferences11:21 EST Wednesday, February 20, 2013ST. LOUIS, Feb. 20, 2013 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that it will present at the following conferences: Citi 2013 Global Healthcare Conference on Wednesday, February 27, 2013 at 9:35 a.m. eastern. Cowen and Company 33rd Annual Healthcare Conference on Wednesday, March 6, 2013 at 9:20 a.m. eastern. These presentations will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com.  RealPlayer or Windows Media Player is needed to listen to the Webcasts and free downloads of these players are available at the Webcast site. The Webcasts will be archived and available for replay for 14 days. Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients ? employers, health plans, unions and government health programs ? we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities ? behavioral sciences, clinical specialization and actionable data ? to create Health Decision Science?, our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter. SOURCE Express ScriptsFor further information: Jeff Hall, Chief Financial Officer, or David Myers, Vice President Investor Relations, +1-314-810-3115, investor.relations@express-scripts.com